stockrow
Friday 6 November 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
52.48
0.53
+1.02%
Follow HTFL
Alert me
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Piotroski F-Score |
— | — | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 7.22 |
P/S ratio |
1.22 | 1.22 | 6.10 |
Altman Z″-Score (non-manufacturers) |
(14.00) | (27.90) | (2.45) |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (3.30) | (2.55) |
P/Operating CF |
(6.65) | (6.65) | (101.39) |
P/B ratio |
0.00 | 0.00 | 3.57 |
Price to Tangible BV |
0.00 | 0.00 | 3.57 |
EV/Sales |
1.91 | 1.91 | 6.13 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(4.38) | (4.38) | (19.99) |
EV/FCF |
(4.17) | (4.17) | (18.29) |
Quick Ratio |
4.37 | 2.27 | 4.87 |
Current Ratio |
4.52 | 2.45 | 5.20 |
Net Debt/EBITDA |
(0.18) | (1.65) | 3.41 |
Debt/Assets |
72.42% | 114.93% | 0.00% |
Debt/Equity |
(14.89) | (1.50) | 0.00 |
Asset Turnover |
0.00 | 0.83 | 0.74 |
Operating CF/Net income |
0.62 | 0.72 | 0.46 |
Capex/Depreciation |
(0.59) | (0.45) | (0.41) |
Interest Coverage |
(2.95) | (2.69) | (4.22) |
| 0.00% | 11.78% | 41.80% | |
| 0.00% | (63.49%) | (48.85%) | |
ROIC |
(2,031.71%) | 0.00% | (32.33%) |
Return on Tangible Assets |
(98.51%) | (167.40%) | (62.65%) |
Average Days of Receivables |
86.03 | 71.48 | 60.84 |
Research and Development Expense of Revenue |
41.13% | 34.59% | 36.88% |
Selling, General and Administrative Expense of Revenue |
109.10% | 89.15% | 76.32% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
13.62% | 8.12% | 7.93% |
Graham Net Nets |
(0.92) | (0.92) | 0.15 |
Graham Number |
0.00 | 254.60 | 0.00 |
Earnings Yield |
(54.94%) | (54.94%) | (27.57%) |
Free Cash Flow Yield |
(37.46%) | (37.46%) | (5.50%) |
Revenue per Share |
17.84 | 23.46 | 4.78 |
Operating CF per Share |
(15.65) | (12.87) | (1.47) |
Capex per Share |
(1.25) | (0.81) | (0.14) |
Free Cash Flow per Share |
(16.90) | (13.68) | (1.60) |
Cash per Share |
25.13 | 9.61 | 4.80 |
Shareholders Equity per Share |
(1.84) | (16.95) | 8.16 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(1.84) | (16.95) | 8.16 |
Free Cash Flow |
(82.54) | (73.36) | (59.05) |
Working Capital |
115.63 | 48.68 | 177.83 |
Capital Expenditures |
(6.10) | (4.36) | (5.02) |
Net Current Asset Value |
(45.60) | (127.33) | 161.40 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.07 | 0.03 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
1.05 | 1.09 | 1.43 |
Cash ROIC |
(33.31%) | (75.60%) | (12.37%) |
Accounts Receivable Turnover |
0.00 | 5.57 | 6.52 |
Accounts Payable Turnover |
0.00 | 10.89 | 13.52 |
Inventory Turnover |
0.00 | 0.00 | 0.00 |
Average Days of Payables |
36.18 | 33.41 | 28.32 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 |
Average Receivables |
— | 22.59 | 26.99 |
Average Payables |
— | 2.88 | 3.02 |
Average Assets |
— | 151.88 | 239.08 |
Average Common Equity |
— | (818.52) | (279.42) |
Columns are period end dates · fundamentals updated 25 Oct 2026